About: The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Treatment Trial (ACCT-1): On Solid Ethical and Scientific Ground

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Treatment Trial (ACCT-1): On Solid Ethical and Scientific Ground Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Treatment Trial (ACCT-1): On Solid Ethical and Scientific Ground
Creator	Mann, Douglas Dubois, James Mozersky, Jessica
source	PMC
abstract	covid:50a8ddb78ab8bdc5b55733b721f7e4b87581ed0e#abstract
has issue date	2020-05-26(xsd:dateTime)
bibo:doi	10.1016/j.jacbts.2020.05.002
has license	no-cc
sha1sum (hex)	50a8ddb78ab8bdc5b55733b721f7e4b87581ed0e
schema:url	https://doi.org/10.1016/j.jacbts.2020.05.002
resource representing a document's title	The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Treatment Trial (ACCT-1): On Solid Ethical and Scientific Ground
has PubMed Central identifier	PMC7250548
schema:publication	JACC Basic Transl Sci
resource representing a document's body	covid:50a8ddb78ab8bdc5b55733b721f7e4b87581ed0e#body_text
is schema:about of	named entity 'social media' named entity 'BTS' named entity 'email' named entity 'placebo-controlled trial' named entity 'evidence-based medicine' named entity 'placebo' named entity 'public health ethics' named entity 'NIAID' named entity 'clinical trial' named entity 'COVID-19' named entity 'public health' named entity 'NIAID' named entity 'remdesivir' named entity 'April 29' named entity 'Steven Nissen' named entity 'ACTT' named entity 'clinical trials' named entity 'clinical trials' named entity 'remdesivir' named entity 'Cleveland Clinic' named entity 'NIH' named entity 'medical knowledge' named entity 'remdesivir' named entity 'remdesivir' named entity 'Declaration of Helsinki' named entity 'placebo' named entity 'COVID-19' named entity 'cardiologist' named entity 'NIAID' named entity 'consent form' named entity 'COVID' named entity 'United States' named entity 'clinical trial' named entity 'RCT' named entity 'Clinical research' named entity 'remdesivir' named entity 'placebo controls' named entity 'placebo' named entity 'ACTT' named entity 'placebo' named entity 'randomized clinical trials' named entity 'remdesivir' named entity 'GROUND' named entity 'ACCT' named entity 'Solid' named entity 'Adaptive' named entity 'Journal' named entity 'Ethical' named entity 'Trial' named entity 'Scientific' named entity 'COVID-19' named entity 'Infectious Diseases' named entity 'ETHICAL' named entity 'NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES' named entity 'COVID-19 TREATMENT' named entity 'SOLID' named entity 'Ground' named entity 'National Institute' named entity 'The National' named entity 'Allergy' named entity 'PRE' named entity 'PROOF' named entity 'SCIENTIFIC' named entity 'JOURNAL ' named entity 'DECISION' named entity 'TRIAL' named entity 'TO STOP' named entity 'ADAPTIVE'
is part of of	covid:50a8ddb78ab8bdc5b55733b721f7e4b87581ed0e#abstract covid:50a8ddb78ab8bdc5b55733b721f7e4b87581ed0e#body_text The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Treatment Trial (ACCT-1): On Solid Ethical and Scientific Ground

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software